Perfil cardiovascular y tolerabilidad En los tres ensayos clnicos, el GLP-1 oral de Lilly mostr mejoras clnicamente significativas respecto a los datos basales en factores clave de riesgo cardiovascular , incluyendo colesterol no HDL, colesterol HDL, colesterol VLDL, colesterol total, presin arterial sistlica y triglicridos
Because GLP-1 medications are highly effective at promoting weight loss, some of the observed benefit may be related to weight reduction
Patients with type 2 diabetes and significant insulin resistance may benefit from optimizing diabetes medications according to American Diabetes Association guidelines
Many companies are now seeking non-pharmaceutical solutions that improve metabolic health and reduce long-term medication dependency
It is also particularly valuable for patients who may have issues with their digestive system that may make other forms of increasing their B12 levels, such as pills and food, less effective